Bolt Biotherapeutics Inc at Guggenheim Healthcare Talks Oncology Day Transcript
Hello again. It's Michael Schmidt from the biotech team at Guggenheim. The next presenting company is Bolt Biotherapeutics. With us today, we have Willie Quinn, CFO; as well as Edith Perez, Chief Medical Officer. Welcome, guys.
Thank you.
Questions & Answers
All right. Why don't we dive right into Q&A? Perhaps for Edith. So ISACs has been a somewhat challenging category for some companies. But on the other hand, there have been a number of partnerships in the last few years in the industry, which suggests there is strategic interest in this technology. Maybe talk about your platform technology and how it's differentiated from others out there.
Yeah, as you said, Michael, there is interest in the technology because one of the reasons for this is that it makes
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
